CSI Market
Sign In | Register

Citius Oncology Inc (TENKU) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access TENKU Annual Cash Flow →
Cash flow patterns shown here provide context for understanding Citius Oncology Inc's ability to sustain operations and capital deployment.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
9 Months 		(Mar 31 2026) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Operating Activities
Income-41.07
Depreciation & amortization0.00
Amortization of Other Assets0.18
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.34
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation11.04
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Amortization Of Inprocess Research And Development2.29
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.69
Accounts Payable0.47
Increase (Decrease) in Accrued Liabilities19.98
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense1.50
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-7.03
Discontinued operations0.00
Net Cash flow from Operating Activities-13.90
Investing Activities
Capital Expenditures-7.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired-40.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net40.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-7.00
Financing Activities
Short-term debt Net9.64
Other borrowing transactions-0.89
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock15.06
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock9.73
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Payments For Underwriting Fees-
Payments For Other Fees-
Payments For Relation To Redemptions Of Ordinary Shares-
Advance From Related Party Debt-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities33.54
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-20.90
Total Cash Flow12.64
4 historic quarters locked

Sign in to unlock the full Citius Oncology Inc cash flow history.

Sign In Create Free Account

About Citius Oncology Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001213900-26-090184

Figures are derived from filed reports and may be restated. Historical data is subject to revision.